Article · 27 Feb 2026
ArticlePublished 29 Aug 2024
Long-Term Safety Profile of Biologic Therapies in Rheumatoid Arthritis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Biologic therapies have transformed the treatment landscape for rheumatoid arthritis (RA), providing targeted interventions that significantly improve clinical outcomes. However, their long-term safety profile remains a crucial consideration for clinicians and patients alike. This article reviews the available evidence on the long-term safety of various biologic agents used in RA, focusing on the risk of infections, malignancies, cardiovascular events, and other adverse effects. While biologics are generally well-tolerated, ongoing surveillance and research are essential to address potential risks and optimize patient safety. This review emphasizes the need for personalized treatment strategies that weigh the benefits of biologics against their long-term safety concerns.
Keywords
Subjects
RheumatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Clinical Rheumatology.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Clinical Rheumatology
- SubjectRheumatology
- BylineArticles whose byline prints “Ahmad Nabil Youssef”